1. Introduction {#sec0005}
===============

Cryptosporidiosis is caused by apicomplexan protozoans of the genus *Cryptosporidium* and is one of the most common agents causing intestinal infection to both humans and livestock worldwide ([@bib0010]). The parasite infects the digestive tract of the major vertebrate groups, including humans, livestock (cattle, sheep, goats, horses and poultry), pets (dogs and cats), etc. ([@bib0010]). In cattle*, Cryptosporidium* spp. infection was first reported in the early 1970s ([@bib0050]). Of the four species commonly found in cattle (*C. parvum*, *C. bovis*, *C. ryanae* and *C. andersoni*), only *C. parvum* is generally associated with clinical disease, especially in neonatal calves ([@bib0025]; [@bib0075]; [@bib0080]). *C. ryanae* and *C. bovis* usually infect older calves and young stock, and *C. andersoni* mainly adults ([@bib0045]). Experimental infections have been carried out and it has been shown that infected animals shed oocysts with no clinical manifestations of the disease ([@bib0080]). The importance of *C. parvum* as an etiological agent of gastroenteritis-like syndrome in dairy calves during their first weeks of life has been confirmed ([@bib0075]). The main clinical signs are diarrhea, dehydration, weakness, anorexia, abdominal pain and mortality ([@bib0025]).

Cryptosporidiosis has been studied in many countries and its prevalence ranges from 3.4 %--96.6 % in pre-weaned calves ([@bib0085]). In Europe, it is considered the most important disease in neonatal calves ([@bib0090]). In Greece, it is a common pathogen associated with neonatal calf diarrhea in dairy cattle farms ([@bib0055]). It causes economic loss ([@bib0090]) and has a negative impact on public health ([@bib0010]; [@bib0025]). The zoonotic nature of *C. parvum* has been confirmed by many studies and new subtypes with infectious potential in both humans and animals have been detected ([@bib0015]; [@bib0025]).

Zoonotic infection occurs most-likely in individuals who have been long in contact with infected animals ([@bib0035]). One of the most important measures to control diarrhea in neonatal calves is colostrum management. The passive transfer of maternal antibodies to newborn calves may reduce the neonatal diarrhea caused by *C. parvum* ([@bib0030]).

The purpose of this study was to determine whether the level of specific anti-*C. parvum* IgG antibodies transferred from dams to neonatal calves through colostrum impacts the development of clinical manifestation of cryptosporidiosis among animals from farms with high prevalence of *C. parvum* infection.

2. Materials and methods {#sec0010}
========================

2.1. Animals and study design {#sec0015}
-----------------------------

This study was conducted during January 2018 and August 2018 in the prefecture of Xanthi, North Greece in five dairy farms with Holstein -- Friesian cows. All farms had documented past records of *C. parvum* infection in neonatal calves. The first ten calves born within the investigation period in each farm and their dams were included in the study. To determine the level of specific IgG antibodies against *Cryptosporidium* in colostrum, the samples were collected within 12 h after birth. Antibody concentration was determined using the single radial immunodiffusion (SRID).

All neonatal calves suckled their dam in the first two hours post-partum. The health condition of calves was daily monitored during the first month of life and fecal samples were collected after diarrhea had been confirmed during this period. Diarrhea in calves is described as manure of looser consistency than normal that persists for 2 or more days, which color can be brown, grey, green or yellow and may contain mucus and blood. The fecal samples were analyzed using an immunochromatographic assay for the four major infectious causes of diarrhea in calves aged up to 30 days: *Rotavirus*, *Coronavirus*, *Escherichia coli* (K99) and *C. parvum.* All samples were transferred and examined at the Laboratory of Parasitology and Microbiology of Veterinary Faculty, University of Thessaly.

2.2. Single radial immunodiffusion {#sec0020}
----------------------------------

Each dam's udder was washed and disinfected with cleaning towelette (MSD). Colostrum samples (100 ml) were individually collected and transferred into sterile tubes labelled with the dam's ear tag number. All samples were stored at −20 °C until IgG analysis. SRID was performed according to the manufacturer's instructions to determine the specific anti-*C. parvum* IgG antibody concentration in colostrum (SRID kit from VMRD Inc. Pullman, WA). The SRID kit contains four reference standards (IgG concentration: 400, 800, 1.600 and 3.200 mg/dl) and 5 plates (12 wells per plate) with mono-specific antisera in buffered agarose. Colostrum samples were transported and further processed at room temperature and fat was removed through centrifugation. An amount of 3 μl of each reference standard was placed into the first wells and the same amount of colostrum sample in the remaining wells, by using a 3 μl precision pipette. The plates were covered and left right-side up at room temperature for 24 h. At 24 h, the diameter of each ring was read by direct measure on the plate and a standard curve was established. The diameters of the reference standards versus their concentrations were plotted on the graph paper provided in the kit. A standard curve was subsequently drawn and used for determination of *Cryptosporidium* IgG antibody concentrations in the colostrum samples.

2.3. Immunochromatographic assay {#sec0025}
--------------------------------

The fecal samples were individually collected from the rectum of each calf using sterile plastic gloves and placed into a clean plastic container, which was labeled with the calf's ear tag number. The sealed samples were stored in an insulated box packed with ice or frozen refrigerant packs. The samples were analyzed by using the immunochromatographic assay for *Rotavirus*, *Coronavirus*, *E. coli* (K99) and *C. parvum* in bovine feces. The analysis was performed using the commercially available dip--stick assay (BIO K156 -- Tetra Calf Scours, BioX Diagnostics S.A, Belgium), according to the manufacturer's instructions. Approximately 0.1 g of feces from each sample was diluted with the reagent provided in the kit. The test strip was dipped into the homogeneous suspension and read after 3 and 10 min of contact. The presence of control line confirmed the validity of the test. Positive results were read as follows: red strip -- Rotavirus-positive, blue strip -- *E. coli* F5-positive, yellow strip -- Corona virus-positive and green strip -- *Cryptosporidium* positive. There were no mixed infections from the other pathogens tested.

2.4. Statistical analysis {#sec0030}
-------------------------

Statistical analysis was performed using the IBM SPSS Statistics 19.0 software. One-way ANOVA was used to compare the mean anti-*C. parvum* IgG antibody concentrations detected in colostrum between farms. *t*-test was used to compare the mean anti-*C. parvum* IgG antibody concentration in the calves with positive and negative results for *C. parvum*. A statistically significant difference was considered if p ≤ 0.05. A point biserial correlation was run to determine the relationship between the level of *C. parvum* IgG antibodies received by a calf and its susceptibility to cryptosporidiosis. The results were considered statistically significant if p≤0.01.

3. Results {#sec0035}
==========

Among the 50 calves included in the study, 18 (36 %) had diarrhea in the first 30 days of life. Of these, 13 (72 % of diarrheic calves) were positive for *C. parvum* without mixed infection with *E coli.*, Coronavirus and Rotavirus.

In all dams, the anti-*C. parvum* IgG antibody concentration in colostrum varied between 570 and 4050 mg/dl; in dams who gave birth to calves with diarrhea and were *C. parvum*-positive, the antibody concentration in colostrum varied between 680 and 3680 mg/dl ([Table 1](#tbl0005){ref-type="table"} ). No statistically significant difference in the level of anti-*C. parvum* IgG antibody concentration in colostrum was observed between farms (p = 0.3165) ([Fig. 1](#fig0005){ref-type="fig"} A). The levels of anti-*C. parvum* IgG antibody concentration in colostrum received by calves with clinical signs of cryptosporidiosis (diarrhea) was significantly lower than in the colostrum received by calves that remained healthy (p = 0.02) ([Fig. 1](#fig0005){ref-type="fig"}B). The point-biserial correlation showed a negative correlation between the levels of anti-*C. parvum* antibodies and the manifestation of clinical cryptosporidiosis (r=-0.425), which was statistically significant (p = 0.002, 2-tailed) ([Fig. 2](#fig0010){ref-type="fig"} ).Table 1IgG antibody concentration in colostrums that calves received in each farm.Table 1Colostrum sampleFarm AFarm BFarm CFarm DFarm E**1**24503480**[750]{.ul}[680]{.ul}**650**2[1650]{.ul}**17508601950570**3**2850**[1810]{.ul}[900]{.ul}**23401930**4**3350276021603310**[3680]{.ul}5[3460]{.ul}**32803460**[890]{.ul}**3970**6**32603100**[1890]{.ul}**28904050**7**2860**[2970]{.ul}[1280]{.ul}**32103890**8**21003150376034903850**9[2370]{.ul}[850]{.ul}**335018703690**10**32101750289019603980Fig. 1A. Mean anti-C. parvum IgG antibody concentration in colostrum observed in each farm. (B) The levels of anti-C. parvum IgG antibody concentration in colostrum received by calves with clinical signs of cryptosporidiosis (diarrhea) compared to the colostrum received by calves that remained healthy.Fig. 1Fig. 2Correlation between the levels of anti-*C. parvum* antibodies and the manifestation of clinical cryptosporidiosis.Fig. 2

4. Discussion {#sec0040}
=============

Importance of colostrum in the passive transfer of immunity and protection of off-springs is well known, as antibodies do not pass through the cow's placenta to the fetus. It contains high concentrations of nutrients, hormones, cytokines, antibodies and a variety of maternal leukocytes that appear to support the growth and maturation of the calf. The neonate calves have a great ability to absorb immunoglobulins and growth factors from the gut (e.g. IgA, IgM, IgG, IGF-1, lactoferrin, and lysozyme) ([@bib0020]). Quality of colostrums is always a crucial factor which ensures that there is sufficient amount of antibodies for absorption by the calves.

Previous studies have shown the existence of *C. parvum-*specific antigenic epitopes on oocysts, which trigger the production of *C. parvum*-antibodies that are detected in serum and colostrum ([@bib0040]). [@bib0005] referred that colostrum management and season of the year influence both the number of *Cryptosporidium spp*. oocysts seeding and the fecal consistency. The antibodies transferred through colostrum offered partial protection against low dose of *C. parvum-*infection ([@bib0040]).

Factors that contribute to the quality of colostrum are the breed and the age of the cow, the season of the year, the appropriate management of cow during the dry period, quality of nutrition and the length of the period are significant. Furthermore, stress and extreme environmental conditions should always be avoided in order to keep a high quality colostrum.

Cryptosporidiosis can cause high rates of morbidity and mortality in calves ([@bib0080]). Calves acquire *C. parvum-*infection shortly after birth and are at a great risk of infection until the age of 1 month ([@bib0060]).

Humans working in close contact with calves are also at risk of *C. parvum* infection ([@bib0065]; [@bib0055]). In addition, massive infections can also be caused by water contamination with domestic or wild animal feces. It is well known that bovine cryptosporidiosis has a serious financial impact on the infected farms. The exact cost should be calculated in each circumstance separately, but surely the cost of treatment and management of enteritis, reduced feed conversion and production efficiency and losses due to animal death should be included in this ([@bib0085]). Preventive care measures should be taken by individuals who are in close contact with infected animals and special attention should be given to the waste management in farms.

Many studies have been carried out to detect *C. parvum* by using ELISA, and it has been shown that this is the most common species found in calves until the age of one month ([@bib0045]). In our study, SRID method was used to quantify *C. parvum* IgG antibody concentration in colostrum and the immunochromatographic assay for detection of *C. parvum* bovine feces. The use of immunochromatographic assay for diagnosis of *C. parvum* infection in individual animals or for screening of animal groups could provide practitioners and researchers a quick and accurate method for detection of infection in young calves at a low cost ([@bib0095]).

Our findings highlight the importance of IgG levels in colostrum fed to neonatal calves during their first day of life for prevention of *C. parvum* infection. The results show a negative correlation between the passive transfer of anti-*C. parvum* IgG antibody through colostrum during the first day of life and the appearance of cryptosporidiosis during the first 30 days of life in calves. These findings suggest that newborn calves are partially protected by colostral antibodies during their first day of life. Similar results have been published by [@bib0100]. Our results highlight the importance of colostrum management in prevention of neonatal diarrhea caused by *Cryptosporidium* spp. in calves and are in line with results from previous studies. Preventive colostrum management leads to protection of calves against cryptosporidiosis through passive immunity ([@bib0005]; [@bib0030]). Moreover, a linear relationship between IgG absorption efficiency and IgG density in colostrum has been demonstrated ([@bib0070]).

We recommend preventive measures against Cryptosporidiosis to be taken in neonatal calves who have been fed with colostrum containing lower levels of anti-*C. parvum* IgG antibodies than the mean level of the farm. These measures include suitable colostrum management and improvement of the immunological status of dams and calves through optimized housing and hygiene conditions, adequate nutrition, elimination of stress factors and other infectious agents, and preventative medication.

Appendix A. Supplementary data {#sec0050}
==============================

The following is Supplementary data to this article:

Supplementary material related to this article can be found, in the online version, at doi:<https://doi.org/10.1016/j.prevetmed.2020.104904>.
